Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-036229
Filing Date
2021-05-27
Accepted
2021-05-27 16:10:32
Documents
1
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3507
  Complete submission text file 0001209191-21-036229.txt   5081
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2401 FOURTH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Bencich John (Reporting) CIK: 0001477056 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 21972767